Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
R

Response Oncology Inc
OTC:ROIX

Watchlist Manager
Response Oncology Inc
OTC:ROIX
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $12
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
-19%
5Y
+39%
10Y
+812%
Operating Income
+
3Y
+93%
5Y
-
10Y
-
Net Income
+
3Y
-191%
5Y
-
10Y
-

Earnings Waterfall
Response Oncology Inc

Income Statement
Response Oncology Inc

Rotate your device to view
Income Statement
Currency: USD
Mar-1992 Jun-1992 Sep-1992 Dec-1992 Mar-1993 Jun-1993 Sep-1993 Dec-1993 Mar-1994 Jun-1994 Sep-1994 Dec-1994 Mar-1995 Jun-1995 Sep-1995 Dec-1995 Mar-1996 Jun-1996 Sep-1996 Dec-1996 Mar-1997 Jun-1997 Sep-1997 Dec-1997 Mar-1998 Jun-1998 Sep-1998 Dec-1998 Mar-1999 Jun-1999 Sep-1999 Dec-1999 Mar-2000 Jun-2000 Sep-2000 Dec-2000 Mar-2001 Jun-2001 Sep-2001 Dec-2001 Mar-2002
Revenue
Revenue
12
N/A
16
+35%
21
+30%
28
+33%
30
+8%
32
+6%
35
+8%
38
+9%
38
+1%
39
+1%
39
+1%
39
-1%
41
+7%
43
+5%
44
+1%
44
+1%
47
+5%
50
+8%
57
+13%
67
+18%
78
+16%
89
+13%
97
+9%
102
+5%
107
+5%
114
+7%
120
+5%
128
+7%
135
+5%
136
+1%
137
+1%
136
-1%
135
-1%
135
+0%
133
-2%
131
-1%
127
-3%
123
-3%
123
0%
118
-4%
109
-7%
Gross Profit
Cost of Revenue
(9)
(12)
(15)
(20)
(22)
(25)
(27)
(30)
(31)
(31)
(32)
(32)
(33)
(33)
(33)
(35)
(35)
(39)
(44)
(30)
(62)
(70)
(77)
(49)
(77)
(73)
(69)
(67)
(73)
(76)
(80)
(80)
(84)
(88)
(89)
(89)
(88)
(88)
(91)
(90)
(85)
Gross Profit
3
N/A
5
+46%
6
+42%
8
+20%
8
+3%
7
-6%
7
-2%
8
+13%
8
-7%
8
+1%
7
-3%
7
-9%
8
+26%
10
+16%
11
+9%
10
-11%
11
+18%
11
+1%
12
+10%
37
+200%
16
-57%
19
+14%
19
+4%
53
+174%
30
-43%
41
+35%
52
+27%
61
+18%
62
+2%
60
-3%
57
-5%
55
-4%
51
-8%
47
-7%
44
-8%
41
-5%
39
-7%
35
-10%
32
-8%
28
-12%
24
-15%
Operating Income
Operating Expenses
(3)
(4)
(5)
(7)
(7)
(7)
(7)
(7)
(8)
(9)
(9)
(9)
(9)
(9)
(9)
(7)
(9)
(9)
(9)
(34)
(10)
(11)
(11)
(42)
(19)
(30)
(40)
(55)
(81)
(81)
(80)
(51)
(49)
(46)
(44)
(43)
(42)
(39)
(36)
(30)
(25)
Selling, General & Administrative
(1)
(2)
(2)
(3)
(3)
(3)
(3)
(3)
(3)
(4)
(4)
(4)
(4)
(5)
(5)
(3)
(5)
(5)
(5)
(21)
(5)
(5)
(5)
(25)
(11)
(17)
(24)
(33)
(33)
(34)
(34)
(32)
(31)
(29)
(28)
(28)
(28)
(26)
(24)
(22)
(19)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
(0)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(4)
(5)
(5)
(5)
(4)
(4)
(5)
(6)
(6)
(6)
(5)
(5)
(5)
(5)
(5)
(5)
(4)
(4)
(4)
(4)
(3)
Other Operating Expenses
(1)
(2)
(3)
(4)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(9)
(2)
(2)
(2)
(12)
(4)
(8)
(11)
(17)
(42)
(41)
(41)
(14)
(13)
(12)
(11)
(10)
(9)
(9)
(8)
(5)
(4)
Operating Income
0
N/A
0
+740%
1
+152%
0
-62%
0
+8%
0
-65%
0
-93%
1
+8 900%
(0)
N/A
(1)
-223%
(1)
-55%
(2)
-69%
(0)
+78%
1
N/A
1
+90%
2
+58%
2
+0%
3
+14%
4
+35%
4
+9%
6
+49%
8
+33%
8
+10%
10
+25%
11
+2%
11
+3%
12
+6%
6
-49%
(19)
N/A
(20)
-7%
(23)
-10%
4
N/A
2
-51%
1
-50%
(0)
N/A
(1)
-479%
(3)
-99%
(4)
-36%
(3)
+11%
(2)
+33%
(1)
+41%
Pre-Tax Income
Interest Income Expense
(0)
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
(0)
(1)
(2)
(3)
(4)
(4)
(4)
(4)
(3)
(3)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(3)
(3)
(2)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(35)
0
0
0
(2)
(2)
(2)
(2)
(16)
(16)
(17)
(17)
(49)
(50)
Pre-Tax Income
0
N/A
1
+1 733%
1
+125%
1
-52%
1
-8%
0
-69%
(0)
N/A
1
N/A
(0)
N/A
(1)
-122%
(2)
-42%
(2)
-48%
(1)
+76%
1
N/A
1
+103%
2
+55%
2
-13%
2
-9%
2
+3%
1
-52%
2
+97%
3
+79%
4
+32%
7
+60%
7
+10%
8
+5%
8
+2%
(33)
N/A
(23)
+31%
(24)
-7%
(26)
-9%
(2)
+94%
(4)
-147%
(5)
-25%
(6)
-27%
(22)
-264%
(23)
-6%
(24)
-6%
(24)
+1%
(54)
-123%
(53)
+2%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
(1)
(2)
(3)
(3)
(3)
(3)
16
5
6
7
(0)
1
1
1
7
8
8
8
3
2
Income from Continuing Operations
0
1
1
1
1
0
(0)
1
(0)
(1)
(2)
(2)
(1)
1
1
2
2
2
2
1
1
2
2
4
5
5
5
(17)
(18)
(19)
(20)
(2)
(3)
(4)
(5)
(14)
(15)
(16)
(16)
(51)
(51)
Net Income (Common)
0
N/A
1
+1 733%
1
+125%
1
-52%
1
-8%
0
-69%
(0)
N/A
1
N/A
(1)
N/A
(1)
-120%
(2)
-42%
(2)
-54%
(1)
+77%
1
N/A
1
+103%
2
+55%
2
-13%
2
-9%
2
+3%
1
-52%
1
+38%
2
+54%
2
+20%
4
+83%
5
+10%
5
+5%
5
+2%
(17)
N/A
(18)
-1%
(19)
-6%
(20)
-7%
(2)
+91%
(3)
-85%
(4)
-19%
(5)
-21%
(14)
-220%
(15)
-6%
(16)
-5%
(16)
+2%
(51)
-224%
(51)
+1%
EPS (Diluted)
0
N/A
0.09
N/A
0.2
+122%
0.09
-55%
0.08
-11%
0.02
-75%
-0.01
N/A
0.1
N/A
-0.06
N/A
-0.15
-150%
-0.22
-47%
-0.34
-55%
-0.08
+76%
0.1
N/A
0.2
+100%
0.32
+60%
0.27
-16%
0.24
-11%
0.24
N/A
0.11
-54%
0.12
+9%
0.15
+25%
0.19
+27%
0.36
+89%
0.39
+8%
0.41
+5%
0.42
+2%
-1.45
N/A
-1.45
N/A
-1.55
-7%
-1.64
-6%
-0.14
+91%
-0.25
-79%
-0.3
-20%
-0.37
-23%
-1.17
-216%
-1.25
-7%
-1.31
-5%
-1.29
+2%
-4.18
-224%
-4.16
+0%

See Also

Summary
ROIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ROIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ROIX stock valuation using valuation multiples.
Wall Street Estimates
ROIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ROIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.